Author: Alexander Naneyshvili

IRMB

Posts by Alexander Naneyshvili

Macromolecular Interactions in Cells, Bioengineering Research Funding Opportunities

0 comments

You may be interested in these recent funding opportunity announcements:

These two announcements are based on a broader initiative for research on macromolecular interactions in cells in vivo. The initiative also includes an additional funding opportunity, Revisions for Macromolecular Interactions in Cells (R01).

  • Collaborations for Macromolecular Interactions in Cells (R01)
    (RFA-GM-14-004)

Purpose: Establish interdisciplinary collaborative projects to advance studies of macromolecular interactions and their relationship to function in cells, tissues and organisms

  • Research Networks for Macromolecular Interactions in Cells (U54)
    (RFA-GM-14-005)

Purpose: Establish interdisciplinary collaborative research networks to advance studies of macromolecular interactions and their relationship to function in cells, tissues and organisms

Letter of intent due date: April 30, 2013
Application due date: May 30, 2013
NIGMS contacts:
Alexandra Ainsztein, 301-594-0828
Daniel Janes, 301-594-0943
Vernon Anderson, 301-594-3827
Paul Brazhnik, 301-451-6446

Bioengineering Research Grants (BRG) (R01)
(PAR-13-137)

Purpose: Develop an innovative technology, model, technique, design or method that infuses principles and concepts from the quantitative sciences to increase our understanding of and solve problems in biological, clinical or translational science
Application due date: Standard dates apply
NIGMS contact: Pamela Marino, 301-594-3827

In addition, several new NIH Common Fund funding opportunities related to workforce development and diversity are listed at http://commonfund.nih.gov

CSR’s Percentiling Recalibration

12 comments

The Center for Scientific Review (CSR) has recently adjusted the base that a number of permanent study sections and special emphasis panels (SEPs) use to calculate percentiles for certain application types. Applications that were reviewed in a SEP meeting for the May 2013 Council round will be assigned a percentile ranking calculated from the new base. In some cases, revised summary statements will be issued for those applications missing percentile scores or with an incorrect percentile. The percentile ranking will also appear in the eRA Commons account of the principal investigator(s).

We here at NIGMS are often asked to explain how percentile rankings factor into determining which awards to make. We do not rely solely on a percentile cutoff; we consider a number of additional factors, including an investigator’s career stage, a laboratory’s other research funding, NIGMS research portfolio balance, and other programmatic priorities. For more information, see http://www.nigms.nih.gov/Research/Application/Pages/SuccessRateFAQs.aspx.

Pain Research, Animal Stem Cell Funding Opportunities

0 comments

You may be interested in these recent funding opportunity announcements:

Mechanisms, Models, Measurement, and Management in Pain Research (R01)
(PA-13-118)

Purpose: Conduct basic, clinical and translational studies on pain related to the missions of the participating NIH institutes and center
Application due dates: Standard dates apply
NIGMS contact: Alison Cole, 301-594-3827

Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)
(PAR-13-114)

Purpose: Propose research aimed at characterizing animal stem cells as well as improving and/or creating animal models for human disease conditions (see announcement for information on NIGMS-specific interests)
Application due dates: Standard dates apply
NIGMS contact: Susan Haynes, 301-594-0943

Macromolecular Interactions in Cells, Biomedical Workforce Diversity and Training

0 comments

You may be interested in these recent funding opportunity announcements:

Revisions for Macromolecular Interactions in Cells (R01)
(RFA-GM-14-003)

Purpose: Extend the scientific scope or enhance research capabilities of active NIGMS-funded R01 or R37 projects specializing in the analysis of molecular systems and mechanisms in live organelles, cells, tissues or organisms
Letter of intent due dates: January 19, 2013; August 19, 2013
Application due dates: February 19, 2013; September 19, 2013
NIGMS contacts:
Alexandra Ainsztein, 301-594-0828
Daniel Janes, 301-594-0943
Vernon Anderson, 301-594-3827
Paul Brazhnik, 301-451-6446

Postbaccalaureate Research Education Program (PREP) (R25)
(PAR-13-085)

Purpose: Prepare recent baccalaureate science graduates from diverse backgrounds who are underrepresented in biomedical and behavioral sciences to pursue and complete Ph.D. or M.D.-Ph.D. degrees in these fields; and increase the diversity of the host institution’s Ph.D. or M.D.-Ph.D. training programs
Application due date: March 14, 2013
NIGMS contact: Michael Bender, 301-594-0943

Initiative for Maximizing Student Development (IMSD) (R25)
(PAR-13-082)

Purpose: Develop new or expand existing institutional developmental programs at research-intensive institutions that prepare undergraduate and graduate students from diverse backgrounds for attaining the Ph.D. degree in biomedical or behavioral sciences and subsequent competitive research careers and leadership positions
Application due date: March 14, 2013
NIGMS contact: Daniel Janes, 301-594-0943

Support of Competitive Research (SCORE) Program, which offers three funding opportunities based on career level that are designed to increase the research competitiveness of faculty at minority-serving institutions and institutions with a historical mission of training students from backgrounds underrepresented in biomedical research

Purpose: Conduct high-quality research and increase research competitiveness by progressively enhancing the pace and productivity of projects
Career level: Advanced formative stage

Purpose: Test a new idea or gather preliminary data to establish a new line of research
Career level: Early academic career

Purpose: Continue engaging in meritorious biomedical or behavioral research projects of limited scope in a given biomedical or behavioral area within the NIH mission
Career level: Intermediate stage

Application due dates: March 4, 2013; May 25, 2013; September 25, 2013
NIGMS contact: Hinda Zlotnik, 301-594-3900

Metabolomics, Human DNA Sequence Variants Funding Opportunities

0 comments

You may be interested in the following funding opportunity announcements:

Collaborative Activities to Promote Metabolomics Research (Admin Supp)
(PA-13-041)

Purpose: Request supplemental funds to current NIH-funded research projects for new interactive collaborations between basic or clinical researchers and metabolomics experts to pursue biomedical studies requiring a metabolomics approach
Application due date: March 15, 2013
NCI contact: Barbara Spalholz, 301-496-7028

New Methods for Understanding the Functional Role of Human DNA Sequence Variants in Complex Phenotypes (R01)
(RFA-GM-14-006)

Purpose: Propose experimental approaches for determining the functional relevance of human DNA sequence variants
Letter of intent due date: January 21, 2013
Application due date: February 21, 2013
NIGMS contact: Donna Krasnewich, 301-594-0943

Ecology and Evolution of Infectious Diseases Funding Opportunity

0 comments

You may be interested in this funding opportunity from an interagency initiative:

NIH-NSF Ecology and Evolution of Infectious Diseases Program: A Joint Program for Multidisciplinary Research
(NOT-TW-12-022)

Purpose: Support research, including field and laboratory studies and model development, focused on the ecological and evolutionary dynamics of infectious disease systems
Application due date: December 05, 2012
NIGMS contact: Irene Eckstrand, 301-594-0943

Dynamics of Host-Associated Microbial Communities, NIH Mentored Research Scientist Development Award in Metabolomics

0 comments

You may be interested in these recent funding opportunity announcements:

Dynamics of Host-Associated Microbial Communities (R01)
(RFA-GM-14-001)

Purpose: Promote genetic, physiological and ecological studies designed to reveal the basic principles and mechanisms that govern the symbiotic systems dynamics of host-associated microbial communities
Letter of intent due date: December 14, 2012
Application due date: January 15, 2013
NIGMS contact: Shiva P. Singh, 301-594-3900

Mentored Research Scientist Development Award in Metabolomics (K01)
(RFA-RM-12-025)

Purpose: Pursue intensive research training in the field of metabolomics under the guidance of an experienced mentor who has an established research record in metabolomics
Application due date: February 28, 2013
NIGMS contact: Richard Okita, 301-594-3827

Meet the NIGMS-Funded PECASE Winners

1 comment

Each year, NIH institutes and centers nominate outstanding young scientists for the Presidential Early Career Award for Scientists and Engineers (PECASE), which is the highest honor bestowed by the U.S. government to individuals beginning their independent research careers. The grantees, who must be new investigators in the first year of an R01 or DP2 award, are selected for their innovative research record, potential to continue on this productive route, and community service activities. In recent years, NIH has annually nominated 20 individuals, with approximately 1 or 2 of them being NIGMS grantees.

Photo of Neils Ringstad (top) and Erica Larschan (bottom).

Among this year’s PECASE recipients are two NIGMS grantees, Niels Ringstad of the Skirball Institute of Biomolecular Medicine at New York University School of Medicine and Erica N. Larschan of Brown University. We identified them because of their cutting-edge neuroscience and developmental genetics research, respectively, and their outstanding commitment to education, mentoring and increasing the diversity of the scientific workforce.

Below, they answer questions about their research and PECASE experience and offer advice to other early career scientists.

What does your research focus on?

Neils Ringstad: Our lab studies the simple behaviors of a small roundworm to identify genes that function in chemical signaling in the nervous system. Even though the organism we study, Caenorabditis elegans, has a tiny nervous system with only 302 neurons, these neurons are very similar to the neurons in our brains and use many of the same neurotransmitters to transmit and process information. We’re particularly interested in serotonin signaling pathways, which are important therapeutic targets in psychiatry.

Erica Larschan: We study how genes are precisely targeted for regulation within the highly compact eukaryotic genome. Gene regulation is a fundamental process that is misregulated in many diseases including cancers. We are interested in identifying new proteins that could serve as targets for anti-cancer therapies.

What was it like to come to Washington, D.C., to meet NIH staff, the President and other PECASE recipients?

Ringstad: It was a tremendous honor to be an awardee. We heard a resounding endorsement of basic science and a clear statement of its value to the American people from both the White House and the NIH. That gave me and my group a boost that will last for years.

Larschan: My PECASE visit was one of the most exciting moments of my scientific career. It was a great opportunity to present brand new data from our lab to a broader audience and interact with the other PECASE winners.

What advice would you give to young investigators?

Ringstad: We pick problems to tackle because we see some good in solving them, and we pick them before we know how tough they are to solve. Don’t lose sight of the hopes and expectations that you had for your project before you did your first experiment.

Larschan: The most important piece of advice is to focus on the most exciting and central questions that you can address with your research. It is essential to use many different approaches to rigorously answer the most difficult questions.

Bridges to the Future Funding Opportunities

0 comments

You may be interested in these recent funding opportunity announcements:

Bridges to the Doctorate Program (R25)
(PAR-12-276)

Purpose: Promote partnerships/consortia between colleges or universities granting a terminal master’s degree and institutions that offer the doctorate degree, with the goal of increasing the pool of master’s degree students from underrepresented backgrounds who pursue research careers in the biomedical and behavioral sciences and who are trained and available to participate in NIH-funded research
Application due date: October 26, 2012
NIGMS contact: Michelle R.J. Hamlet, 301-594-3900

Bridges to the Baccalaureate Program (R25)
(PAR-12-277)

Purpose: Promote partnerships/consortia between community colleges or other 2-year post-secondary educational institutions granting the associate degree and colleges or universities that offer the baccalaureate degree, with the goal of increasing the pool of community college students from underrepresented backgrounds who pursue research careers in the biomedical and behavioral sciences and will be available to participate in NIH-funded research
Application due date: October 26, 2012
NIGMS contact: Michelle R.J. Hamlet, 301-594-3900

Update on NIH Special Council Review Policy

1 comment

NIH has announced a new policy whereby applications from investigators who receive more than $1 million in direct research support from active NIH grants will receive additional scrutiny by NIH institute and center (IC) advisory councils. This is a threshold, not a cap: Investigators may still receive additional grant awards if the ICs determine such awards will further their missions.

A few notes: The policy replaces a piloted one that set the threshold at $1.5 million total costs. NIGMS will continue its current practice that sets the threshold for special scrutiny of well-funded investigators at $750,000 or more in direct costs for all research support, regardless of the source.

Below is a chart that outlines some of the differences between the NIH and NIGMS policies. For more discussion on this topic, see comments to my earlier post.

NIH

NIGMS

Funding source

NIH only

NIH and non-NIH

Threshold

$1M direct costs on existing grants

$750K direct costs including the pending application

Exclusions

RFAs, P01s, some multi-PI awards

Resource awards